Premia Real Estate Investment Company Societe Anonyme (ATH:PREMIA)
1.388
-0.002 (-0.14%)
At close: Aug 8, 2025, 5:20 PM EET
Ligand Pharmaceuticals Market Cap
ATH:PREMIA has a market cap or net worth of €130.19 million as of August 8, 2025. Its market cap has increased by 29.76% in one year.
Market Cap
130.19M
Enterprise Value
425.76M
Revenue
22.35M
Ranking
n/a
PE Ratio
2.99
Stock Price
$1.39
Market Cap Chart
Since January 4, 2008, ATH:PREMIA's market cap has increased from 64.64M to 130.19M, an increase of 101.42%. That is a compound annual growth rate of 4.06%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 130.19M | 18.78% |
Dec 31, 2024 | 109.61M | 8.95% |
Dec 29, 2023 | 100.60M | 7.10% |
Dec 30, 2022 | 93.93M | -33.44% |
Dec 31, 2021 | 141.12M | 398.84% |
Dec 31, 2020 | 28.29M | 1,988.40% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Prodea Real Estate Investment Company Société Anonyme | 1.52B |
LAMDA Development | 1.15B |
Trastor Real Estate Investment Company | 301.03M |
Dimand | 183.70M |
BriQ Properties Real Estate Investment Company | 131.36M |
Alpha Real Estate Services | 101.64M |
Kekrops | 32.18M |